Physician
Brian Le DO PC
Brian Le DO PC was paid $1.05M by Medicaid between Jan 2018 and Dec 2024, across 24 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 61% of everything it billed.
33Billing provider infoBRIAN LE DO PC
LAS VEGAS, NV 89129
LAS VEGAS, NV 89129
33aNPI1598070914assigned 08/10/2010
33bProvider typeAnesthesiology Physician
28Total paid$1.05M
24GClaims33,197
24DCodes billed24
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in Nevada
Rank by total paid#3 of 129
Median peer was paid$32K
This provider vs. median33×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,501 | $85K | |
| 2019 | 5,583 | $170K | |
| 2020 | 4,103 | $128K | |
| 2021 | 5,306 | $184K | |
| 2022 | 6,651 | $204K | |
| 2023 | 4,823 | $164K | |
| 2024incomplete | 3,230 | $116K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 61% | 19,666 | 17,079 | $639K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 1,912 | 1,763 | $129K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8.8% | 798 | 766 | $93K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.2% | 2,207 | 1,974 | $55K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.4% | 1,674 | 1,459 | $26K |
| 99152 | 2.0% | 701 | 571 | $21K | |
| 95886 | 1.6% | 128 | 92 | $16K | |
| 80305 | 1.4% | 3,353 | 3,054 | $14K | |
| 20553 | 1.2% | 411 | 338 | $12K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.1% | 208 | 202 | $12K |
| 01992 | <1% | 236 | 186 | $8K | |
| 64616 | <1% | 105 | 98 | $7K |
12 more codes
| 95913 | <1% | 42 | $7K | |
| 95874 | <1% | 90 | $4K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 75 | $3K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 771 | $3K |
| 20611 | <1% | 55 | $2K | |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.) | <1% | 58 | $1K |
| 77002 | <1% | 14 | $447.01 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 332 | $14.16 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 100 | $7.82 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 44 | $6.55 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 49 | $5.15 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 168 | $0.23 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLE, BRIAN (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Ibrite Dental - Cleburne, PLLC | Cleburne, TX | $1.27M |
| Ibrite Dental PLLC | Fort Worth, TX | $395K |
| Blossom Smile Dental, PLLC | Euless, TX | $264K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.